Haleon plc Haleon plc

Haleon plc

HLN

Classifica tra le azioni #13654
Haleon plc operates as a global entity focused on developing, manufacturing,... Haleon plc operates as a global entity focused on developing, manufacturing, and marketing an array of consumer health products. Its operations extend across multiple continents, specifically North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers a comprehensive selection of items, encompassing therapeutic oral care, pain relief solutions, respiratory health aids, digestive wellness products, as well as vitamins, minerals, and other dietary supplements. Prominent brands within its extensive portfolio include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The firm, incorporated in 2021, was initially named DRVW 2022 plc before rebranding to Haleon plc in February 2022. Its corporate headquarters are located in Brentford, United Kingdom.
Prezzo delle azioni
$5.12
Capitalizzazione di mercato
$449.99M
Variazione (1 giorno)
-0.45%
Variazione (1 anno)
8.63%
Paese
GB
Scambia Haleon plc (HLN)

Categoria

Healthcare
Cronologia dei frazionamenti azionari per Haleon plc (HLN)
L’azione Haleon plc (simbolo: HLN) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Oct 20, 2026.
Una quota di HLN acquistata prima di Oct 20, 2026 equivale oggi a 0 quote di HLN.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti